| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |